Phanstiel; Otto

Patent Applications and Registrations

Patent applications and USPTO patent grants for Phanstiel; Otto.The latest application filed is for "formation of n-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-n-protected amino ester".

Company Profile

8.16.15

Phanstiel; Otto - Oviedo FL
Phanstiel; Otto - Clifton Park NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formation Of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine Through A Cyclic Alpha-n-protected Amino Ester App 20220289687 - Freeman; John J. ; et al.	2022-09-15
Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic .alpha.-N-protected amino ester Grant 11,345,668 - Freeman , et al. May 31, 2	2022-05-31
Methods for the synthesis of activated ethylfumarates and their use as intermediates App 20210114994 - Kraft; Kelly Sullivan ; et al.	2021-04-22
Formation Of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine Through A Cyclic Alpha-n-protected Amino Ester App 20210107880 - Freeman; John J. ; et al.	2021-04-15
Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic .alpha.-N-protected amino ester Grant 10,870,628 - Freeman , et al. December 22, 2	2020-12-22
Methods for the synthesis of activated ethylfumarates and their use as intermediates Grant 10,858,325 - Kraft , et al. December 8, 2	2020-12-08
Formation Of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine Through A Cyclic Alpha-n-protected Amino Ester App 20200199082 - Freeman; John J. ; et al.	2020-06-25
Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester intermediate Grant 10,577,331 - Freeman , et al.	2020-03-03
Immunomodulatory Compounds App 20190365673 - Gilmour; Susan ; et al.	2019-12-05
Methods for the synthesis of activated ethylfumarates and their use as intermediates App 20190010131 - Kraft; Kelly Sullivan ; et al.	2019-01-10
Methods for the synthesis of activated ethylfumarates and their use as intermediates Grant 10,071,969 - Kraft , et al. September 11, 2	2018-09-11
Formation Of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine Through A Cyclic Alpha-n-protected Amino Ester Intermediate App 20180230107 - Freeman; John J. ; et al.	2018-08-16
Formation of N-protected bis-3,6-(4-aminobutyl)-2, 5-diketopiperazine through a cyclic alpha-N-protected amino ester Grant 9,944,609 - Freeman , et al. April 17, 2	2018-04-17
Formation Of N-protected Bis-3,6- (4-aminobutyl) -2, 5-diketopiperazine Through A Cyclic Alpha-n-protected Amino Ester App 20160137614 - Freeman; John J. ; et al.	2016-05-19
Polyamine transport inhibitors as novel therapeutics Grant 9,212,131 - Phanstiel , et al. December 15, 2	2015-12-15
Methods for the synthesis of activated ethylfumarates and their use as intermediates Grant 9,193,691 - Kraft , et al. November 24, 2	2015-11-24
Formation of N-protected 3,6-bis-(4-aminobutyl) -2, 5-diketopiperazine through a cyclic .alpha.-N-protected active amino ester intermediate Grant 9,187,433 - Freeman , et al. November 17, 2	2015-11-17
Formation Of N-protected Bis-3,6- (4-aminobutyl) -2, 5-diketopiperazine Through A Cyclic Alpha-n-protected Amino Ester App 20150259301 - Freeman; John J. ; et al.	2015-09-17
Formation of N-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine through a cyclic alpha-N-protected amino ester Grant 8,962,836 - Freeman , et al. February 24, 2	2015-02-24
Formation Of N-protected Bis-3,6-(4-aminobutyl)-2,5-diketopiperazine Through A Cyclic Alpha-n-protected Amino Ester App 20140288304 - Freeman; John J. ; et al.	2014-09-25
Polyamine Transport Inhibitors As Novel Therapeutics App 20120172449 - Phanstiel; Otto ; et al.	2012-07-05
Motuporamine Mimic Agents App 20100240747 - Phanstiel; Otto	2010-09-23
Motuporamine mimic agents Grant 7,728,041 - Phanstiel June 1, 2	2010-06-01
Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs Grant 7,728,040 - Phanstiel June 1, 2	2010-06-01
Motuporamine Mimic Agents App 20090069441 - Phanstiel; Otto	2009-03-12
Motuporamine mimic agents App 20070213397 - Phanstiel; Otto	2007-09-13
Polyamine conjugates as selective NMDA inhibitors and anti-cancer drugs App 20070088081 - Phanstiel; Otto	2007-04-19
Compounds and method for enhancing the efficacy of anti-cancer drugs Grant 7,001,925 - Phanstiel February 21, 2	2006-02-21
Substituted triazine-capped polyphenylene ethers Grant 5,210,191 - Phanstiel , et al. May 11, 1	1993-05-11
Copolymer-containing compositions from substituted triazine-capped polyphenylene ethers Grant 5,089,567 - Phanstiel , et al. * February 18, 1	1992-02-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.